Evaluation of Efficacy of Lumbar Plexus Bloc After Hip Surgery

U

University Hospital, Angers

Status

Completed

Conditions

Postoperative
Pain

Treatments

Drug: ropivacaine

Study type

Interventional

Funder types

Other

Identifiers

NCT00150865
CP 02-01

Details and patient eligibility

About

Compare lumbar plexus block with ropivacaine 0.475%, 0.4 ml/kg to saline. Each group randomized, includes 30 patients. block performed preoperatively Surgery under general anesthesia. Postoperative evaluation of pain (VAS) as first endpoint, and also morphine consumption via PCA device. Follow-up : 24h. Expectation : sizeable reduction of pain with block, of duration.

Full description

Compare lumbar plexus block (randomized) ropivacaine 0.475%, 0.4 ml/kg saline 0.4 ml/kg . Each group includes 30 patients. Block performed preoperatively. Surgery under general anesthesia (sufentanil, propofol, atracurium ; maintenance : sevoflurane and nitrous oxide in O2. Sufentanil added peroperatively as clinically needed. Postoperative evaluation of pain (VAS, by an independant blind observer) as first endpoint, and also morphine consumption via PCA device. Adverse effects (nausea, vomiting, etc) recorded Follow-up : 24h. Expectation : sizeable reduction of pain with block, of duration.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

* adults * ASA 1-3

Exclusion criteria

* cognitive impairement * ASA IV

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Double Blind

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems